STYCAST 1267, PART A CLEAR

Storage

Store in a cool, dry location with adequate ventilation. Keep container tightly sealed when not in use. Keep away from open flames and heat sources. Consult the product Technical Bulletin for detailed storage information. SECTION 8: HEALTH DATA

Principle Routes of Exposure

Skin and eye contact, inhalation of vapors.

Medical Conditions Generally Aggravated by Exposure

Exposure may aggravate preexisting skin and/or eye disorders. Eye Contact: Contains materials irritating to the eyes. Symptoms may include blurred vision, burning sensation and tearing. Skin Contact: Contains materials which cause moderate skin irritation. Prolonged or repeated exposure to the liquid may exert a defatting or drying action on the skin, possibly resulting in dermatitis. This product may cause skin sensitization/allergic skin reactions which may be severe in certain individuals; symptoms include rash, itching, hives, swelling of the extremities. Inhalation: Heating can generate vapors that may cause respiratory irritation, nausea and headaches. Inhalation hazard at room temperature is unlikely, due to the low volatility of this product. Ingestion: Harmful if swallowed. Printed: 09/17/1999 Page: 3 The information given and the recommendations made herein apply to our product(s) alone and are not combined with other product(s). Such are based on our research and on data from other reliable sources and are believed to be accurate. No guaranty of accuracy is made. STYCAST 1267, PART A CLEAR

Potential chronic health

Although the significance is unknown, the DGEBA epoxy resin in this product has been shown to be mutagenic in some microbial tests, but has failed to show mutagenicity in others. Chromosomal aberrations were observed in cultured rat liver cells. Two-year bioassays on mice exposed by the dermal route to DGEBA resins yielded only very limited evidence of weak carcinogenicity. Based on this and other evidence, the International Agency for Research on Cancer (IARC) concluded in 1988 that DGEBA epoxy resins are not classifiable as carcinogens. SECTION 9: FIRST AID PROCEDURES Eye Contact: Flush eyes thoroughly with water for at least 15 minutes while holding eyelids open. Get medical attention. Skin Contact: Remove any contaminated clothing and flush the affected area of the skin thoroughly with plenty of water. Follow by washing with soap and water. Get medical attention if irritation persists. Do not reuse contaminated clothing until properly cleaned. Inhalation: Remove victim to fresh air. Provide oxygen if breathing is difficult. Give artificial respiration if not breathing. Get immediate medical attention. Ingestion: Dilute by giving plenty of water to drink, if victim is conscious and alert. Never give anything by mouth to a drowsy, unconscious, or convulsing person. Get immediate attention.

Additional information

Product NPCA Hazardous Material Identification System (HMIS) Rating: Health: 2 Flammability: 1 Reactivity: 0 TSCA Status:. All components of this product are listed in the EPA Toxic Substance Control Act Inventory. This product contains the following substances which are subject to TSCA subject to TSCA Section 12(b) Export notification requirements: Diglycidyl Ether of Bisphenol A (1675-54-3) Foreign Inventory Status: Canadian DSL: All components listed or exempt European EINECS: All components listed or exempt Japanese MITI ENCS: Not determined Korean ECL: One component not listed Australian AICS: All components listed SARA Status: Printed: 09/17/1999 Page: 4 The information given and the recommendations made herein apply to our product(s) alone and are not combined with other product(s). Such are based on our research and on data from other reliable sources and are believed to be accurate. No guaranty of accuracy is made. STYCAST 1267, PART A CLEAR